PRISM BioLab Investors
PRISM develop therapeutic drugs that cure these intractable diseases using our unique peptide mimic technology.
Connections
Industry:
Advanced and Next Generation Therapies (Various)
Headquarters:
Fujisawa, Kanagawa, Japan
Founded Date:
2006
Investor Type:
Healthcare Company